Ionetix Corp / DE /

Ionetix Corp is a Delaware-incorporated radiopharmaceutical company operating in the nuclear medicine sector, with a focus on the production of medical isotopes used in diagnostic imaging and emerging theranostic applications. The company filed an 8-K with the SEC on April 16, 2026, under accession number 0001213900-26-044239, reflecting ongoing public-company reporting obligations. Ionetix operates cyclotron-based production infrastructure to supply fluorine-18 and other short-lived radionuclides to imaging centers and pharmaceutical partners. The company entered the public markets through a special purpose acquisition vehicle and remains an active filer with the Commission. For comprehensive data on Ionetix Corp, including filing history, deal structure, and sponsor details, sign up for full access at SpacDesk.